Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.75M Sell
98,755
-18,808
-16% -$877K 0.01% 1081
2025
Q4
$5.7M Buy
117,563
+1,586
+1% +$78.6K 0.01% 954
2025
Q3
$5.47M Sell
115,977
-81,581
-41% -$3.94M 0.01% 881
2025
Q2
$9.54M Buy
197,558
+5,720
+3% +$292K 0.01% 623
2025
Q1
$10.6M Buy
191,838
+82,841
+76% +$4.48M 0.02% 538
2024
Q4
$5.26M Buy
108,997
+8,107
+8% +$412K 0.01% 782
2024
Q3
$5.81M Buy
100,890
+2,447
+2% +$132K 0.01% 728
2024
Q2
$4.78M Buy
98,443
+7,146
+8% +$345K 0.01% 745
2024
Q1
$4.44M Buy
91,297
+1,880
+2% +$91.8K 0.01% 778
2023
Q4
$4.45M Sell
89,417
-2,313
-3% -$113K 0.01% 725
2023
Q3
$4.92M Buy
91,730
+8,179
+10% +$436K 0.01% 644
2023
Q2
$4.5M Buy
83,551
+1,827
+2% +$98.3K 0.01% 678
2023
Q1
$4.45M Buy
81,724
+4,040
+5% +$197K 0.01% 674
2022
Q4
$3.76M Buy
77,684
+18,400
+31% +$808K 0.01% 703
2022
Q3
$2.25M Buy
59,284
+28,814
+95% +$1.28M 0.01% 727
2022
Q2
$1.52M Buy
30,470
+2,299
+8% +$122K 0.01% 784
2022
Q1
$1.45M Buy
28,171
+4,272
+18% +$221K 0.01% 825
2021
Q4
$1.2M Buy
23,899
+3,647
+18% +$180K 0.01% 782
2021
Q3
$976K Buy
20,252
+3,562
+21% +$181K 0.01% 707
2021
Q2
$879K Buy
16,690
+514
+3% +$26.8K 0.01% 688
2021
Q1
$800K Buy
16,176
+2,868
+22% +$138K 0.01% 657
2020
Q4
$647K Buy
13,308
+2,329
+21% +$115K 0.01% 638
2020
Q3
$551K Buy
10,979
+717
+7% +$36.9K 0.01% 599
2020
Q2
$524K Sell
10,262
-2,746
-21% -$133K 0.01% 596
2020
Q1
$569K Buy
+13,008
New +$622K 0.01% 566
2019
Q4
Sell
-11,379
Closed -$527K 716
2019
Q3
$527K Buy
11,379
+3,120
+38% +$135K 0.01% 594
2019
Q2
$357K Sell
8,259
-3,557
-30% -$151K ﹤0.01% 821
2019
Q1
$523K Buy
11,816
+1,274
+12% +$54.6K 0.01% 652
2018
Q4
$458K Buy
10,542
+889
+9% +$39.2K 0.01% 587
2018
Q3
$431K Buy
+9,653
New +$412K 0.01% 589

Other funds holding SNY

Mariner's SNY Position: Q1 2026 in Review

Mariner reduced its Sanofi (SNY) stake by 16% in Q1 2026, selling an estimated $877K and leaving 98,755 shares worth $4.75M. The position accounts for 0.01% of the portfolio, ranked #1081.

Mariner first reported a position in SNY in Q3 2018 and has held it in 30 quarters since. The position peaked at $10.6M in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Mariner held 98,755 shares of Sanofi worth $4.75M as of Q1 2026.
  • Mariner sold 18,808 Sanofi shares in Q1 2026, an estimated $877K.
  • Sanofi made up 0.01% of Mariner's portfolio in Q1 2026, its #1081 holding.
  • Mariner first reported a position in Sanofi in Q3 2018 and has held it in 30 quarters since.
  • Mariner's Sanofi position peaked at $10.6M in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.